Cytokinetics Inc. buy Royal Bank of Canada
Start price
18.12.24
/
50%
€45.80
Target price
18.12.25
€78.17
Performance (%)
23.36%
Price
10:37
€56.50
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 23.36%. This prediction currently runs until 18.12.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -2.564% | -2.564% |
| iShares Core DAX® | 1.330% | -1.723% |
| iShares Nasdaq 100 | 1.099% | -2.569% |
| iShares Nikkei 225® | 1.265% | -6.613% |
| iShares S&P 500 | 1.000% | -0.871% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target raised by analysts at Royal Bank of Canada from $80.00 to $82.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat